Collectively, the in vitro and in vivo findings presented here reveal that breast cancer cells initiate a cytoprotective autophagic response in a STK11-dependent manner to evade HNK efficacy which can be potentiated by combining an autophagy inhibitor with HNK treatment. Here, STK11 is linked to breast carcinoma.